Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

Clinical trial NCT00672243 · COMPLETED

Trial details

NCT number: NCT00672243
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma

Start date: 2007-04-01
Primary completion: 2008-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.